Copyright
©The Author(s) 2015.
World J Hepatol. May 8, 2015; 7(7): 916-921
Published online May 8, 2015. doi: 10.4254/wjh.v7.i7.916
Published online May 8, 2015. doi: 10.4254/wjh.v7.i7.916
Figure 2 Prevalence of multiresistant bacterial infections according to the site of acquisition.
Multiresistant bacteria are present predominantly in the nosocomial and healthcare associated (HCA) infections. P value in both graphics refers to χ2 linear-by-linear association statistic (original work of the author).
- Citation: Acevedo J. Multiresistant bacterial infections in liver cirrhosis: Clinical impact and new empirical antibiotic treatment policies. World J Hepatol 2015; 7(7): 916-921
- URL: https://www.wjgnet.com/1948-5182/full/v7/i7/916.htm
- DOI: https://dx.doi.org/10.4254/wjh.v7.i7.916